Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Entrepreneurs June 08, 2021 Mexican woman wins award for creating device against parasitic disease Social Skin rewards young people who have innovative social impact projects. This year, a Tec de Monterrey student is one of the winners.
Health May 11, 2021 Tec students create global health convergence platform Medical students from the Tec want to create agents of social change through a digital community focused on public and global health.
Institution May 05, 2021 3 years of alliance of the best private universities in Latin America The holding of this year’s virtual summit of rectors from La Tríada, an alliance between the Tec, Chile’s Catholic University, and Colombia’s UNIANDES.
Institution May 05, 2021 Global rankings highlight Tec as university with social impact THE Impact Rankings 2021 highlight Tec de Monterrey as a world-leading university for social impact.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Institution April 21, 2021 Global recognition! Tec given award for innovation by SAP SAP, a market leader in business software, has presented Tec de Monterrey with an award for Innovation in the Higher Education and Research category.
Institution April 19, 2021 Tec and University of Illinois to design furniture trends Tec de Monterrey and the University of Illinois will exchange proposals on innovative and flexible furniture design for the new normal.
Research April 12, 2021 Tec is world leader in using AI to detect diabetic retinopathy For enabling early detection in places where there are no expert ophthalmologists physically present, the Tec’s project was incorporated into the “Global Partnership on Artificial Intelligence” (GPAI).
Research February 24, 2021 Nobel laureate calls for trust in scientific consensus on vaccines Aaron Ciechanover, an Israeli scientist who won the 2004 Nobel Prize in Chemistry, calls for increased media campaigns in favor of COVID-19 vaccination.
